SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-096568
Filing Date
2020-08-18
Accepted
2020-08-18 16:56:40
Documents
3
Period of Report
2020-08-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2028898-1_8k.htm 8-K 17600
2 EXHIBIT 99.1 tm2028898d1_ex99-1.htm EX-99.1 15330
3 GRAPHIC tm2028898d1_ex99-1img001.jpg GRAPHIC 15408
  Complete submission text file 0001104659-20-096568.txt   55517
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 201114379
SIC: 2834 Pharmaceutical Preparations